|
PLOS ONE 2012
An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian CancerDOI: 10.1371/journal.pone.0008274 Abstract: Recent studies have shown that DNA methylation (DNAm) markers in peripheral blood may hold promise as diagnostic or early detection/risk markers for epithelial cancers. However, to date no study has evaluated the diagnostic and predictive potential of such markers in a large case control cohort and on a genome-wide basis.
|